152 related articles for article (PubMed ID: 34653395)
1. Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease.
Alexander JL; Selinger CP; Powell N;
Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):987-988. PubMed ID: 34653395
[No Abstract] [Full Text] [Related]
2. SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy.
Selim R; Wellens J; Marlow L; Satsangi JJ
Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):989. PubMed ID: 34655528
[No Abstract] [Full Text] [Related]
3. Delaying the second dose of covid-19 vaccines.
Pimenta D; Yates C; Pagel C; Gurdasani D
BMJ; 2021 Mar; 372():n710. PubMed ID: 33737404
[No Abstract] [Full Text] [Related]
4. Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic.
Melmed GY; Rubin DT; McGovern DPB
Gastroenterology; 2021 Feb; 160(3):639-644. PubMed ID: 33065064
[No Abstract] [Full Text] [Related]
5. Managing Immunosuppressed Patients With Inflammatory Bowel Disease During a Measles Outbreak.
Cohen ER; Salem M; Ha C
Am J Gastroenterol; 2019 Oct; 114(10):1563-1565. PubMed ID: 31498155
[No Abstract] [Full Text] [Related]
6. Turkish IBD Organization's Position Statement on Inflammatory Bowel Disease Management Recommendations During COVID-19 Pandemic.
Törüner M; Kalkan İH; Akyüz F; Tezel A; Çelik AF
Turk J Gastroenterol; 2021 Jun; 32(6):488-492. PubMed ID: 34405814
[TBL] [Abstract][Full Text] [Related]
7. Considerations in boosting COVID-19 vaccine immune responses.
Krause PR; Fleming TR; Peto R; Longini IM; Figueroa JP; Sterne JAC; Cravioto A; Rees H; Higgins JPT; Boutron I; Pan H; Gruber MF; Arora N; Kazi F; Gaspar R; Swaminathan S; Ryan MJ; Henao-Restrepo AM
Lancet; 2021 Oct; 398(10308):1377-1380. PubMed ID: 34534516
[No Abstract] [Full Text] [Related]
8. Antibody Responses After SARS-CoV-2 mRNA Vaccination in Adults With Inflammatory Bowel Disease.
Melmed GY; Botwin GJ; Sobhani K; Li D; Prostko J; Figueiredo J; Cheng S; Braun J; McGovern DPB
Ann Intern Med; 2021 Dec; 174(12):1768-1770. PubMed ID: 34633830
[No Abstract] [Full Text] [Related]
9. [We must respect the anti-SARS-CoV-2 vaccine schedule without delay in cancer patients under treatment].
Barrière J; Audigier-Valette C; Borchiellini D; Hoch B; Castelnau O; Francois E; Gastaud L; Skaf R; Berdah JF; Marie W; Lescaut W; Peyrade F; Cluzeau T; Cassuto O; Carles M
Bull Cancer; 2021 Apr; 108(4):341-342. PubMed ID: 33741139
[No Abstract] [Full Text] [Related]
10. UK science advisers: publish evidence behind COVID vaccine changes.
Nature; 2021 Jan; 589(7841):169-170. PubMed ID: 33437064
[No Abstract] [Full Text] [Related]
11. Could mixing COVID vaccines boost immune response?
Ledford H
Nature; 2021 Feb; 590(7846):375-376. PubMed ID: 33547431
[No Abstract] [Full Text] [Related]
12. Challenges in paediatric inflammatory bowel diseases in the COVID-19 time.
Dipasquale V; Cucchiara S; Martinelli M; Miele E; Aloi M; Romano C
Dig Liver Dis; 2020 May; 52(5):593-594. PubMed ID: 32276846
[No Abstract] [Full Text] [Related]
13. COVID vaccine boosters: the most important questions.
Callaway E
Nature; 2021 Aug; 596(7871):178-180. PubMed ID: 34354274
[No Abstract] [Full Text] [Related]
14. In brief: Booster doses of mRNA-based COVID-19 vaccines for all adults.
Med Lett Drugs Ther; 2021 Dec; 63(1640):201-202. PubMed ID: 35100238
[No Abstract] [Full Text] [Related]
15. SARS-CoV-2 vaccination in IBD: more pros than cons.
D'Amico F; Rabaud C; Peyrin-Biroulet L; Danese S
Nat Rev Gastroenterol Hepatol; 2021 Apr; 18(4):211-213. PubMed ID: 33473178
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021.
Embi PJ; Levy ME; Naleway AL; Patel P; Gaglani M; Natarajan K; Dascomb K; Ong TC; Klein NP; Liao IC; Grannis SJ; Han J; Stenehjem E; Dunne MM; Lewis N; Irving SA; Rao S; McEvoy C; Bozio CH; Murthy K; Dixon BE; Grisel N; Yang DH; Goddard K; Kharbanda AB; Reynolds S; Raiyani C; Fadel WF; Arndorfer J; Rowley EA; Fireman B; Ferdinands J; Valvi NR; Ball SW; Zerbo O; Griggs EP; Mitchell PK; Porter RM; Kiduko SA; Blanton L; Zhuang Y; Steffens A; Reese SE; Olson N; Williams J; Dickerson M; McMorrow M; Schrag SJ; Verani JR; Fry AM; Azziz-Baumgartner E; Barron MA; Thompson MG; DeSilva MB
MMWR Morb Mortal Wkly Rep; 2021 Nov; 70(44):1553-1559. PubMed ID: 34735426
[TBL] [Abstract][Full Text] [Related]
17. The appropriate use of vaccines in patients with inflammatory bowel disease.
Lodhia N
J Clin Gastroenterol; 2014; 48(5):395-401. PubMed ID: 24518799
[TBL] [Abstract][Full Text] [Related]
18. How can countries stretch COVID vaccine supplies? Scientists are divided over dosing strategies.
Ledford H
Nature; 2021 Jan; 589(7841):182. PubMed ID: 33437062
[No Abstract] [Full Text] [Related]
19. Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial.
Matsumoto H; Ohfuji S; Watanabe K; Yamagami H; Fukushima W; Maeda K; Kamata N; Sogawa M; Shiba M; Tanigawa T; Tominaga K; Watanabe T; Fujiwara Y; Hirota Y; Arakawa T
J Gastroenterol; 2015 Aug; 50(8):876-86. PubMed ID: 25672513
[TBL] [Abstract][Full Text] [Related]
20. [Vaccination against SARS-CoV-2 in patients with multiple sclerosis].
Costa Frossard-França L; García-Domínguez JM; Moreno-Torres I; Fortún J; Villar LM; Meca-Lallana V
Rev Neurol; 2021 Apr; 72(7):250-260. PubMed ID: 33764494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
